Other
Neoplasm by Site
CI-CAN-00000003Explore in graph →
Non-malignant20,485 active trials253 approved drugs3,567 evidence items
Loading cancer entity…
Other
CI-CAN-00000003Explore in graph →
Clinical trials
92,566 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00154726 | Paclitaxel-HDFL for Locally Advanced and Recurrent/Metastatic Gastric Cancers | completed | Phase 2 | 40 | National Taiwan University HospitalOTHER | 0 | Nov 22, 2005 | clinicaltrials |
| NCT00154817 | A Phase II Study of Radiotherapy for Locally Advanced Hepatocellular Carcinoma (HCC) | completed | Phase 2 | 12 | National Taiwan University HospitalOTHER | 0 | Nov 22, 2005 | clinicaltrials |
| NCT00209833 | Treatment of Adults Aged Up to 60 Years With De Novo Acute Myeloblastic Leukaemia,Secondary AML, or RAEB-T | unknown | Phase 2 / Phase 3 | 200 | Hannover Medical SchoolOTHER | 1 | Nov 18, 2005 | clinicaltrials |
| NCT00254319 | Previously Untreated Advanced Non-Small Cell Lung Cancer (NSCLC) | unknown | Phase 2 | — | The Cooper Health SystemOTHER | 1 | Nov 16, 2005 | clinicaltrials |
| NCT00078065 | Xcellerated T CellsTM in Patients With Multiple Myeloma | completed | Phase 2 | 30 | Xcyte TherapiesINDUSTRY | 1 | Nov 11, 2005 | clinicaltrials |
| NCT00111046 | Pain Relief - Tramadol Versus Ibuprofen | unknown | Phase 1 / Phase 2 | 40 | Royal Liverpool University HospitalOTHER_GOV | 1 | Nov 10, 2005 | clinicaltrials |
| NCT00250874 | Myocet, Docetaxel & Trastuzumab as 1st Line Treatment of Patients With HER-2/Neu Positive Metastatic Breast Cancer | unknown | Phase 2 | 45 | Zeneus PharmaINDUSTRY | 1 | Nov 8, 2005 | clinicaltrials |
| NCT00179751 | A Phase I/II Study of Lenalidomide in Combination With Gemcitabine in Patients With Untreated Advanced Carcinoma of the Pancreas | terminated | Phase 1 / Phase 2 | 50 | Celgene CorporationINDUSTRY | 1 | Nov 7, 2005 | clinicaltrials |
| NCT00231075 | Evaluation of the Safety and Efficacy of Paraplatin in Combination With Taxol in Patients of 70 Years and Older With Ovary Cancer F.I.G.O. Stages III-IV | completed | Phase 2 | 75 | ARCAGY/ GINECO GROUPOTHER | 1 | Nov 3, 2005 | clinicaltrials |
| NCT00245362 | A Phase II Trial of CG 8020 and CG 2505 in Patients With Nonresectable or Metastatic Pancreatic Cancer | completed | Phase 2 | 50 | Cell GenesysINDUSTRY | 1 | Oct 28, 2005 | clinicaltrials |
| NCT00238849 | Phase II Study of Oxaliplatin and Navelbine for Second-Line Treatment of Advanced NSCLC. | unknown | Phase 2 | 40 | Integrated Community Oncology NetworkOTHER | 1 | Oct 14, 2005 | clinicaltrials |
| NCT00215345 | A Phase II Trial of Combination Therapy With Celecoxib and Taxotere for the Treatment of Stage D3 Prostate Cancer | unknown | Phase 2 | 66 | Department of Veterans Affairs, New JerseyFED | 1 | Sep 22, 2005 | clinicaltrials |
| NCT00218205 | A Study of Epirubicin With Estramustine Phosphate and Celecoxib for the Treatment of Prostate Cancer | unknown | Phase 2 | 28 | Department of Veterans Affairs, New JerseyFED | 1 | Sep 22, 2005 | clinicaltrials |
| NCT00209625 | Phase I / II Study of Irinotecan (CPT-11) Combined With l-Leucovorin (l-LV) and 5-FU in Patients With Advanced Colorectal Cancer | completed | Phase 1 / Phase 2 | 23 | Hokkaido Gastrointestinal Cancer Study GroupOTHER | 1 | Sep 21, 2005 | clinicaltrials |
| NCT00201318 | A Randomized Study in Non-Hodgkin's Lymphoma Patients Carrying Hepatitis B Surface Antigen | completed | Phase 2 | 50 | National Health Research Institutes, TaiwanOTHER | 1 | Sep 20, 2005 | clinicaltrials |
| NCT00188370 | Ultrasound Biomicroscopy - Apoptosis | completed | Phase 2 | 50 | University Health Network, TorontoOTHER | 1 | Sep 16, 2005 | clinicaltrials |
| NCT00175747 | A Phase IIb Trial of Pulmicort Turbuhaler (Budesonide) | completed | Phase 2 / Phase 3 | 120 | University of British ColumbiaOTHER | 1 | Sep 15, 2005 | clinicaltrials |
| NCT00164437 | CD-ROM Intervention for Prostate Cancer Screening | completed | Phase 2 / Phase 3 | 554 | Centers for Disease Control and PreventionFED | 1 | Sep 14, 2005 | clinicaltrials |
| NCT00154713 | Immunotherapy for Colorectal Cancers Using CEA-Pulsed Dendritic Cells and Subsequent IL-2 Treatment | unknown | Phase 1 / Phase 2 | 37 | National Taiwan University HospitalOTHER | 1 | Sep 12, 2005 | clinicaltrials |
| NCT00155272 | Radiotherapy Plus Thalidomide in Locally Advanced Hepatocellular Carcinoma | unknown | Phase 1 / Phase 2 | 19 | National Taiwan University HospitalOTHER | 1 | Sep 12, 2005 | clinicaltrials |
| NCT00152087 | A Non-Randomized Study of Internal Radiation Therapy to the Liver in Patients With Primary Liver Cancer for Whom Surgery is Not Possible. | unknown | Phase 2 | 25 | St. Joseph's Hospital, FloridaOTHER | 1 | Sep 9, 2005 | clinicaltrials |
| NCT00140374 | Vaccination Priming and Vaccine Boosting Trial of Allogeneic Human GM-CSF Gene Transduced Irradiated Prostate Cancer Cell Vaccines (GVAX® Vaccine for Prostate Cancer) | completed | Phase 1 / Phase 2 | 36 | Cell GenesysINDUSTRY | 0 | Sep 1, 2005 | clinicaltrials |
| NCT00140387 | Prime-Boost Dose Scheduling Trial for Human GM-CSF Gene Transduced Irradiated Prostate Allogeneic Cancer Cell Vaccines (Allogeneic Prostate GVAX®) | completed | Phase 1 / Phase 2 | 20 | Cell GenesysINDUSTRY | 0 | Sep 1, 2005 | clinicaltrials |
| NCT00140400 | Prime-Boost Dose Scheduling Trial for Human GM-CSF Gene Transduced Irradiated Prostate Allogeneic Cancer Vaccine (Allogeneic Prostate GVAX®) in Patients With Hormone-Refractory Prostate Cancer | completed | Phase 1 / Phase 2 | 50 | Cell GenesysINDUSTRY | 0 | Sep 1, 2005 | clinicaltrials |
| NCT00139633 | Selective Dose Escalation for Esophageal Cancer | unknown | Phase 2 | 25 | The Oregon ClinicOTHER | 1 | Aug 31, 2005 | clinicaltrials |
| NCT00073385 | Comparative Trial of Pivanex and Docetaxel Vs Docetaxel Monotherapy in Patients With Advanced Non-Small Cell Lung Cancer | completed | Phase 2 | 225 | Titan PharmaceuticalsINDUSTRY | 3 | Aug 30, 2005 | clinicaltrials |
| NCT00083473 | A Pilot Study of Pivanex in Patients With Chronic Lymphocytic Leukemia | terminated | Phase 2 | 28 | Titan PharmaceuticalsINDUSTRY | 1 | Aug 30, 2005 | clinicaltrials |
| NCT00126243 | Efficacy of Rituximab and Cyclophosphamide, Doxorubicin, Vincristine, Prednisone (CHOP) in Patients With HIV Associated Non-Hodgkin's Lymphoma | terminated | Phase 2 | 60 | French National Agency for Research on AIDS and Viral HepatitisOTHER_GOV | 1 | Aug 17, 2005 | clinicaltrials |
| NCT00116155 | Trial of IV Injection of CV787 in Hormone Refractory Metastatic Prostate Cancer | completed | Phase 1 / Phase 2 | — | Cell GenesysINDUSTRY | 0 | Jun 28, 2005 | clinicaltrials |
| NCT00002003 | Phase II Study of Novantrone(R) (Mitoxantrone) and Etoposide in Patients With HIV Associated Large Cell and Immunoblastic Lymphomas | completed | Phase 2 | — | Lederle LaboratoriesINDUSTRY | 1 | Jun 24, 2005 | clinicaltrials |
| NCT00002131 | A Pilot Study of OPC-8212 (Vesnarinone) in Persons With AIDS-Related Kaposi's Sarcoma | completed | Phase 2 | 28 | Otsuka America PharmaceuticalINDUSTRY | 1 | Jun 24, 2005 | clinicaltrials |
| NCT00002167 | Photodynamic Therapy Clinical Trial For Cutaneous AIDS-Related Kaposi's Sarcoma Study Summary. | completed | Phase 2 | 78 | Clinical SolutionsINDUSTRY | 1 | Jun 24, 2005 | clinicaltrials |
| NCT00002185 | A Pilot, Open-Label, Phase II, Randomized Study to Determine the Effects of Viracept on the Outcome of Cutaneous and Mucosal KS in AIDS Patients With CD4 <= 500 Cells/mm3 | completed | Phase 2 | 20 | Agouron PharmaceuticalsINDUSTRY | 1 | Jun 24, 2005 | clinicaltrials |
| NCT00002188 | A Study of ALRT1057 in Patients With AIDS-Related Kaposi's Sarcoma | completed | Phase 2 | 27 | Anderson Clinical ResearchINDUSTRY | 0 | Jun 24, 2005 | clinicaltrials |
| NCT00002189 | Paclitaxel in Advanced Refractory Kaposi's Sarcoma (AIDS-KS): A Phase II Trial of Paclitaxel From Baker Norton Pharmaceuticals | completed | Phase 2 | — | Baker Norton PharmaceuticalsINDUSTRY | 1 | Jun 24, 2005 | clinicaltrials |
| NCT00002212 | A Study of Targretin Capsules in Patients With AIDS-Related Kaposi's Sarcoma | completed | Phase 2 | 27 | Ligand PharmaceuticalsINDUSTRY | 1 | Jun 24, 2005 | clinicaltrials |
| NCT00002221 | Gene Therapy in HIV-Positive Patients With Non-Hodgkin's Lymphoma | completed | Phase 2 | 5 | RibozyomeINDUSTRY | 1 | Jun 24, 2005 | clinicaltrials |
| NCT00002259 | Phase II Study of Intravenous Novantrone(R) in the Treatment of AIDS Related Kaposi's Sarcoma | completed | Phase 2 | — | Lederle LaboratoriesINDUSTRY | 1 | Jun 24, 2005 | clinicaltrials |
| NCT00002314 | A Study of Ro 24-7429 in Patients With HIV-Related Kaposi's Sarcoma | completed | Phase 2 | — | Hoffmann-La RocheINDUSTRY | 1 | Jun 24, 2005 | clinicaltrials |
| NCT00004659 | Phase II Randomized Study of Stereotactic Radiosurgery Plus Fractionated Whole-Brain Radiotherapy Vs Fractionated Whole-Brain Radiotherapy Alone for Multiple Primary or Metastatic Brain Tumors | unknown | Phase 2 | 40 | National Institute of Neurological Disorders and Stroke (NINDS)NIH | 0 | Jun 24, 2005 | clinicaltrials |
| NCT00005931 | SU5416 in Patients With AIDS-Related Kaposi's Sarcoma Who Have Not Responded to Treatment | completed | Phase 2 | 30 | SUGENINDUSTRY | 1 | Jun 24, 2005 | clinicaltrials |
| NCT00006198 | Chronic Thalidomide Administration in Patients Undergoing Chemoembolization for Unresectable Hepatocellular Cancer | unknown | Phase 2 | — | National Center for Research Resources (NCRR)NIH | 1 | Jun 24, 2005 | clinicaltrials |
| NCT00006332 | Treatment of Hepatocellular Carcinoma With Tetrathiomolybdate | completed | Phase 2 | — | National Center for Research Resources (NCRR)NIH | 1 | Jun 24, 2005 | clinicaltrials |
| NCT00006433 | Phase I/II Trial of Doxil and Hyperthermia for Breast Cancer Patients With Chest Wall Recurrence or Stage IV Disease With Locally Advanced Breast Cancer | unknown | Phase 2 | — | National Center for Research Resources (NCRR)NIH | 1 | Jun 24, 2005 | clinicaltrials |
| NCT00013806 | CHP677: I-Metaiodobenzylguanidine (I-MIBG) Therapy for Refractory Neuroblastoma: a Phase II Study | unknown | Phase 2 | — | National Center for Research Resources (NCRR)NIH | 1 | Jun 24, 2005 | clinicaltrials |
| NCT00022932 | Safety and Efficacy of Iodine-131 Anti-B1 Antibody for Intermediate Grade Non-Hodgkin's Lymphoma Following First Line CHOP | unknown | Phase 2 | — | Corixa CorporationINDUSTRY | 1 | Jun 24, 2005 | clinicaltrials |
| NCT00022945 | Safety and Efficacy Study of Iodine-131 Anti-B1 Antibody Plus CHOP For Untreated Mantle Cell Lymphoma | completed | Phase 2 | — | Corixa CorporationINDUSTRY | 1 | Jun 24, 2005 | clinicaltrials |
| NCT00028158 | Safety and Effectiveness Study of G207, a Tumor-Killing Virus, in Patients With Recurrent Brain Cancer | completed | Phase 1 / Phase 2 | 65 | MediGeneINDUSTRY | 0 | Jun 24, 2005 | clinicaltrials |
| NCT00034333 | Safety and Efficacy of Doxorubicin Adsorbed to Magnetic Beads Vs. IV Doxorubicin in Treating Liver Cancer | terminated | Phase 2 / Phase 3 | 240 | FeRxINDUSTRY | 8 | Jun 24, 2005 | clinicaltrials |
| NCT00036426 | Idiotype Vaccine for Low-Grade Non-Hodgkin's Lymphoma | unknown | Phase 2 | 22 | FavrilleINDUSTRY | 1 | Jun 24, 2005 | clinicaltrials |
Data updated 22 days agoSource updated Nov 22, 2005source: clinicaltrials